Thus, these findings reveal a strong link between aberrant STMN2 expression and MN degeneration in ALS and imply that restoring STMN2 levels is a promising therapeutic approach for TDP-43-dependent ALS. This evidence concerns the gene STMN2 and amyotrophic lateral sclerosis.